Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | PDE1B | Q01064 | 10/20 | 0.40 |
| ▸ | DGAT1 | O75907 | 2/20 | 0.39 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.39 |
| ▸ | PDE2A | O00408 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | NAPEPLD | Q6IQ20 | 1/20 | 0.38 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.37 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.37 |
| ▸ | WNT3A | P56704 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31602029 | 0.90 | THRB (0.39) | THRBPDE1BDGAT1SOAT1PDE2A | |
| SCHEMBL31601778 | 0.86 | ALDH1A1 (0.40) | THRBPDE1BDGAT1SOAT1MAPT | |
| SCHEMBL31601923 | 0.86 | THRB (0.38) | THRBPDE1BDGAT1SOAT1MAPT | |
| SCHEMBL31601789 | 0.86 | DGAT1 (0.40) | THRBPDE1BDGAT1SOAT1MAPT | |
| SCHEMBL31601796 | 0.85 | THRB (0.38) | THRBPDE1BDGAT1SOAT1MAPT | |
| SCHEMBL31601961 | 0.83 | THRB (0.36) | THRBPDE1BDGAT1SOAT1PDE2A | |
| SCHEMBL31601920 | 0.78 | DGAT1 (0.42) | THRBPDE1BDGAT1SOAT1MAPT | |
| SCHEMBL31601670 | 0.77 | ALDH1A1 (0.37) | PDE1BMAPTKEAP1NFE2L2 | |
| SCHEMBL31601750 | 0.77 | PDE1B (0.39) | THRBPDE1BMAPT | |
| SCHEMBL31601761 | 0.77 | ALDH1A1 (0.36) | PDE1BLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025110815-A1 | IMIDAZO [1,2-B] PYRIDAZINE-BASED NOVEL COMPOUND AS CDK INHIBITOR AND USE THEREOF | 아이리드비엠에스 주식회사 | 2025-05-30 | — | — | WO | disclosed |